DCBLD2 and cancer: In most cases, DCBLD2 expression is moderately positive and strongly associated with the quantity of multiple infiltrating immune cells, such as neutrophils, cancer-associated fibroblasts (CAFs), endothelial cells, and myeloid-derived suppressor cells (MDSCs), in different types of cancer.